Clinical trial design data for electrocardiogram artificial intelligence-guided screening for low ejection fraction (EAGLE)

Xiaoxi Yao, Rozalina G. McCoy, Paul A. Friedman, Nilay D. Shah, Barbara A. Barry, Emma M. Behnken, Jonathan W. Inselman, Zachi I. Attia, Peter A. Noseworthy

Research output: Contribution to journalArticlepeer-review

Abstract

The article details the materials that will be used in a clinical trial - ECG AI-Guided Screening for Low Ejection Fraction (EAGLE): Rationale and design of a pragmatic cluster randomized trial [1]. It includes a clinician-facing action recommendation report that will translate an artificial intelligence algorithm to routine practice and an alert when a positive screening result is found. This report was developed using a user-centered approach via an iterative process with input from multiple physician groups. Such data can be reused and adapted to translate other artificial intelligence algorithms. This article also includes data collection forms we developed for the clinical trial aiming to evaluate the artificial intelligence algorithm. Such materials can be adapted for other clinical trials.

Original languageEnglish (US)
Article number104894
JournalData in Brief
Volume28
DOIs
StatePublished - Feb 2020

Keywords

  • Artificial intelligence
  • Clinical trial
  • Electrocardiogram
  • Heart failure

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Clinical trial design data for electrocardiogram artificial intelligence-guided screening for low ejection fraction (EAGLE)'. Together they form a unique fingerprint.

Cite this